Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination

Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination

BACKGROUND:. The U.S. Food and Drug Administration has to date granted approval or emergency use authorization to three vaccines against severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019. In clinical trials and real-use observational studies, the Pfizer-BioNTech BNT162b2 m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benjamin Kahn, BA, Sokratis A. Apostolidis, MD, Vatsal Bhatt, MD, Allison R. Greenplate, PhD, Staci Kallish, DO, Anthony LaCava, MD, Alfredo Lucas, BA, Nuala J. Meyer, MD, MS, Dan Negoianu, MD, Alexis R. Ogdie, MD, MSCE, Michael G. S. Shashaty, MD, MSCE, Patricia A. Takach, MD, Leah Zuroff, MD, MS, E. John Wherry, PhD, George L. Anesi, MD, MSCE, MBE
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Acceso en línea:https://doaj.org/article/2bf181e5ca184060a76eb3a8b345f61c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2bf181e5ca184060a76eb3a8b345f61c

Ejemplares similares